|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61K 31/4985 | |||
| C07D 487/04 | |||
| A61P 35/00 |
| (11) | Number of the document | 2785325 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12798565.3 |
| Date of filing the European patent application | 2012-11-30 | |
| (97) | Date of publication of the European application | 2014-10-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/067172 |
| Date | 2012-11-30 |
| (87) | Number | WO 2013/082344 |
| Date | 2013-06-06 |
| (30) | Number | Date | Country code |
| 201161566109 P | 2011-12-02 | US | |
| 201261647288 P | 2012-05-15 | US | |
| 201261653439 P | 2012-05-31 | US | |
| 201261670419 P | 2012-07-11 | US |
| (72) |
CONNOLLY, Terrence, Joseph, US
KLOPFER, Kevin, Joseph, US
LEONG, William, Wei-Hwa, US
MENON, Anil, US
MIKLOS, Amanda, Nicole, US
KREILEIN, Matthew Michael, US
GAMBOA, Juan Antonio, US
XU, Jean, US
BOERSEN, Nathan, US
HUI, Ho-Wah, US
LEE, Thomas, CN
LI, Ying, US
COHEN, Benjamin, US
|
| (73) |
Signal Pharmaceuticals, LLC,
10300 Campus Point Drive, Suite 100, San Diego, CA 92121,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE |
| PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE |